Skip to main content
Log in

Clinical applicability of human in vivo localized phosphorus-31 magnetic resonance spectroscopy of bone and soft tissue tumors

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Background: Magnetic resonance imaging (MRI) is of restricted value for the in vivo characterization of tumor types. The applicability of phosphorus-31 (31P) magnetic resonance spectroscopy (MRS) in the diagnosis of bone and soft tissue tumors is unknown.

Methods: A total of 191 consecutive patients (85 females and 106 males; mean age 41 years, range 1–80) with a well-defined bone or soft tissue tumor on MRI were analyzed for additional31P spectroscopy. Histology and/or cytology was obtained from all tumors. Because of low sensitivity of the31P nucleus and the contamination of surrounding tissue, only large, superficially located tumors accessible to the surface coil could be accepted for MRS.

Results: Twenty-one patients (11%) could be included in the study. From this remaining group only 12 studies (57%) produced spectra with well resolved phosphorus peaks and an acceptable signal-to-noise ratio. However, these spectra did not allow differentiation between the benign and malignant nature of the lesions. The other 9 studies showed spectra with poor signal intensities and/or poorly defined peaks, making tumor differentiation impossible.

Conclusion: Only 6% of the bone and soft tissue tumors produced well defined spectra, which implies that localized31P MRS cannot be considered as a routine technique in the diagnostic and treatment evaluation of bone and soft tissue tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ehman RL, Berquist TH, McLeod RA. MR imaging of the musculoskeletal system: a 5-year appraisal.Radiology 1988;166:313–320.

    CAS  PubMed  Google Scholar 

  2. Sundaram M, McGuire MH: Computed tomography or magnetic resonance for evaluating the solitary tumor or tumor-like lesion of bone?Skeletal Radiol 1988;17:393–401.

    CAS  PubMed  Google Scholar 

  3. Pettersson H, Gillespy T III, Hamlin DJ, et al. Primary musculoskeletal tumors: examination with MR imaging compared with conventional modalities.Radiology 1987;164:237–41.

    CAS  PubMed  Google Scholar 

  4. Bloem JL, Taminiau AHM, Eulderink F, Hermans J, Pauwels EKJ. Radiologic staging of primary bone sarcoma: MR imaging, scintigraphy, angiography, and CT correlated with pathologic examination.Radiology 1988;169:805–10.

    CAS  PubMed  Google Scholar 

  5. Stoker DJ. Management of bone tumours. The radiologist's role.Clin Radiol 1989;40:233–9.

    Article  CAS  PubMed  Google Scholar 

  6. Demas BE, Heelan RT, Lane J, Marcove R, Hajdu S, Brennan MF. Soft-tissue sarcomas of the extremities: comparison of MR and CT in determining the extent of disease.AJR 1988;150:615–20.

    CAS  PubMed  Google Scholar 

  7. Petasnick JP, Turner DA, Charters JR, Gitelis S, Zacharias C. Soft-tissue masses of the locomotor system: comparison of MR imaging with CT.Radiology 1986;160:125–33.

    CAS  PubMed  Google Scholar 

  8. Tehranzadeh J, Mnaymneh W, Ghavam C, Morillo G, Murphy BJ. Comparison of CT and MR imaging in musculoskeletal neoplasms.J Comput Assist Tomogr 1989;13:466–72.

    CAS  PubMed  Google Scholar 

  9. Chang AE, Matory YL, Dwyer AJ, et al. Magnetic resonance imaging versus computed tomography in the evaluation of soft tissue tumors of the extremities.Ann Surg 1987;205:340–8.

    CAS  PubMed  Google Scholar 

  10. Aisen AM, Martel W, Braunstein EM, McMillin KI, Philips WA, King TF. MRI and CT evaluation of primary bone and soft-tissue tumors.AJR 1986;146:749–56.

    CAS  PubMed  Google Scholar 

  11. Hogeboom WR, Hoekstra HJ, Mooyaart EL, Freling NJM, Schraffordt Koops H: MRI and CT in the preoperative evaluation of soft-tissue tumors.Arch Orthop Trauma Surg 1991;110:162–4.

    CAS  PubMed  Google Scholar 

  12. Hogeboom WR, Hoekstra HJ, Mooyaart EL, et al. MRI or CT in the preoperative diagnosis of bone tumors.Eur J Surg Oncol 1992;18:67–72.

    CAS  PubMed  Google Scholar 

  13. Sundaram M, McGuire MH, Herbold DR. Magnetic resonance imaging of soft tissue masses: an evaluation of fifty-three histologically proven tumors.Magn Reson Imaging 1988;6:237–48.

    CAS  PubMed  Google Scholar 

  14. Sundaram M, McLeod RA. MR imaging of tumor and tumorlike lesions of bone and soft tissue.AJR 1990;155:817–24.

    CAS  PubMed  Google Scholar 

  15. Kransdorf MJ, Jelinek JS, Moser RP Jr, et al. Soft-tissue masses: diagnoses using MR imaging.AJR 1989;153:541–7.

    CAS  PubMed  Google Scholar 

  16. Totty WG, Murphy WA, Lee JKT. Soft-tissue tumors: MR imaging.Radiology 1986;160:135–41.

    CAS  PubMed  Google Scholar 

  17. Hogeboom WR, Hoekstra HJ, Mooyaart EL, et al. The role of magnetic resonance imaging and computed tomography in the treatment evaluation of retroperitoneal lymph-node metastases of non-seminomatous testicular tumors.Eur J Radiol 1991;13:31–6.

    Article  CAS  PubMed  Google Scholar 

  18. Hogeboom WR, Hoekstra HJ, Mooyaart EL, et al. Magnetic resonance imaging (MRI) in evaluating in vivo response to neoadjuvant chemotherapy for osteosarcomas of the extremities.Eur J Surg Oncol 1989;15:424–30.

    CAS  PubMed  Google Scholar 

  19. Hogeboom WR, Hoekstra HJ, Mooyaart EL, et al. Magnetic resonance imaging of retroperitoneal lymph node metastases of non-seminomatous germ cell tumors of the testis.Eur J Surg Oncol 1993;19:429–37.

    CAS  PubMed  Google Scholar 

  20. Griffiths JR, Cady E, Edwards RTH, McCready VR, Wilkie DR, Wiltshaw E. 31P-NMR studies of a human tumour in situ [Letter].Lancet 1983;1:1435–6.

    CAS  PubMed  Google Scholar 

  21. Oberhaensli RD, Hilton-Jones D, Bore PJ, Hands LJ, Rampling RP, Radda GK. Biochemical investigation of human tumours in vivo with phosphorus-31 magnetic resonance spectroscopy.Lancet 1986;2:8–11.

    CAS  PubMed  Google Scholar 

  22. McKenna WG, Lenkinski RE, Hendrix RA, Vogele KE, Bloch P. The use of magnetic resonance imaging and spectroscopy in the assessment of patients with head and neck and other superficial human malignancies.Cancer 1989;64:2069–75.

    CAS  PubMed  Google Scholar 

  23. Vogl T, Peer F, Schedel H, et al. 31P-spectroscopy of head and neck tumors—surface coil technique. Magnetic resonance imaging 1989;7:425–35.

    Article  CAS  PubMed  Google Scholar 

  24. Ross B, Helsper JT, Cox J, et al: Osteosarcoma and other neoplasms of bone. Magnetic resonance spectroscopy to monitor therapy.Arch Surg 1987;122:1464–9.

    CAS  PubMed  Google Scholar 

  25. Zlatkin MB, Lenkinski RE, Shinkwin M, et al. Combined MR imaging and spectroscopy of bone and soft tissue tumors.J Comput Assist Tomogr 1990;14:1–10.

    CAS  PubMed  Google Scholar 

  26. Negendank WG, Crowley MG, Ryan JR, Keller NA, Evelhoch JL. Bone and soft-tissue lesions: diagnosis with combined H-1 MR imaging and P-31 MR spectroscopy.Radiology 1989;173:181–8.

    CAS  PubMed  Google Scholar 

  27. Redmond OM, Stack JP, Dervan PA, Hurson BJ, Carney DN, Ennis JT. Osteosarcoma: use of MR imaging and MR spectroscopy in clinical decision making.Radiology 1989;172:811–5.

    CAS  PubMed  Google Scholar 

  28. Semmler W, Gückel F, Bachert-Baumann P, Lorenz WJ, van Kaick G: Anwendung der multinuklearen in vivo Magnetresonanzspektroskopie in der Onkologie.Radiologe 1989;29:330–5.

    CAS  PubMed  Google Scholar 

  29. Semmler W, Gademann G, Bachert-Baumann P, Zabel HJ, Lorenz WJ, van Kaick G: Monitoring human tumor response to therapy by means of P-31 MR spectroscopy.Radiology 1988;166:533–9.

    CAS  PubMed  Google Scholar 

  30. Majors AW, Ng TC, Xue M, Meaney TF. Monitoring therapeutic response of human superficial tumors using phaseencoded spectroscopy.Magn Reson Med 1989;12:369–78.

    CAS  PubMed  Google Scholar 

  31. Koutcher JA, Ballon D, Graham M, et al: 31P NMR spectra of extremity sarcomas: diversity of metabolic profiles and changes in response to chemotherapy.Magn Reson Med 1990;16:19–34.

    CAS  PubMed  Google Scholar 

  32. Ng TC, Majors AW, Vijayakumar S, et al. Human neoplasm pH and response to radiation therapy: P-31 MR spectroscopy studies in situ.Radiology 1989;170:875–8.

    CAS  PubMed  Google Scholar 

  33. Bryant DJ, Bydder GM, Case HA, et al. Use of phosphorus-31 MR spectroscopy to monitor response to chemotherapy in non-Hodgkin lymphoma.J Comput Assist Tomogr 1988;12:770–4.

    CAS  PubMed  Google Scholar 

  34. Just M, Gutjahr P, Juretschke HP, et al. 31Phosphorspektroskopie bei osteogenem Sarkom. Möglichkeiten der Therapiekontrolle im Vergleich mit bildgebenden Verfahren.Fortschr Rontgenstr 1987;146:144–8.

    CAS  Google Scholar 

  35. Lenkinski RE, Listerud J, Shinkwin MA, et al. Magnetic resonance imaging and magnetic resonance spectroscopy of bone tumors and bone marrow disease.Invest Radiol 1989;24:1006–10.

    CAS  PubMed  Google Scholar 

  36. Luyten PR, Groen JP, Vermeulen JWAH, den Hollander JA. Experimental approaches to image localized human 31P NMR spectroscopy.Magn Reson Med 1989;11:1–21.

    CAS  PubMed  Google Scholar 

  37. Veen JWC vd, Beer R de, Luyten PR, van Ormondt D. Accurate quantification of in vivo 31P NMR signals using the variable projection method and prior knowledge.Magn Reson Med 1988;6:92–8.

    PubMed  Google Scholar 

  38. Bottomeley PA. Human in vivo NMR spectroscopy in diagnostic medicine: clinical tool or research probe.State Art Radiol 1989;170:1–15.

    Google Scholar 

  39. Semmler VW, Gademann G, Bachert-Baumann P, et al. In vivo 31 Phosphor-Spektroskopie von Tumoren: prae-, intraund posttherapeutisch.Fortschr Rontgenstr 1988;149:369–77.

    CAS  Google Scholar 

  40. Negendank WC, Brown TR, Evelhoch JL, et al. Magnetic resonance spectroscopy: proceedings of a National Cancer Institute Workshop: MR spectroscopy and tumor cell biology.Radiology 1992;185:875–83.

    CAS  PubMed  Google Scholar 

  41. Bore P: 31P-NMR studies of human tumours [Letter].Lancet 1983;2:458–9.

    CAS  PubMed  Google Scholar 

  42. Sostman HD, Charles HC, Rockwell S, et al. Soft-tissue sarcomas: detection of metabolic heterogeneity with P-31 MR spectroscopy.Radiology 1990;176:837–43.

    CAS  PubMed  Google Scholar 

  43. Karczmar GS, Meyerhoff DJ, Boska MD, et al. P-31 spectroscopy study of response of superficial human tumors to therapy.Radiology 1991;179:149–53.

    CAS  PubMed  Google Scholar 

  44. Merchant TE. Editorial: the importance of magnetic resonance spectroscopy in surgical oncology.Eur J Surg Oncol 1993;19:111–4.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hoekstra, H.J., Boeve, W.J., Kamman, R.L. et al. Clinical applicability of human in vivo localized phosphorus-31 magnetic resonance spectroscopy of bone and soft tissue tumors. Annals of Surgical Oncology 1, 504–511 (1994). https://doi.org/10.1007/BF02303616

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02303616

Key Words

Navigation